HBK Sorce Advisory’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
HBK Sorce Advisory's BSX Position: Q2 2026 in Review
HBK Sorce Advisory increased its Boston Scientific (BSX) stake by 1.5% in Q2 2026, buying an estimated $6.95K and bringing the position to 8,430 shares worth $402K. The position accounts for 0.01% of the portfolio, ranked #431.
HBK Sorce Advisory first reported a position in BSX in Q4 2018 and has held it in 16 quarters since. The position peaked at $914K in Q2 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- HBK Sorce Advisory held 8,430 shares of Boston Scientific worth $402K as of Q2 2026.
- HBK Sorce Advisory bought 128 Boston Scientific shares in Q2 2026, an estimated $6.95K.
- Boston Scientific made up 0.01% of HBK Sorce Advisory's portfolio in Q2 2026, its #431 holding.
- HBK Sorce Advisory first reported a position in Boston Scientific in Q4 2018 and has held it in 16 quarters since.
- HBK Sorce Advisory's Boston Scientific position peaked at $914K in Q2 2025.
- 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on HBK Sorce Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.